Filana Therapeutics (FLNA) Revenue (2010 - 2013)

Filana Therapeutics has reported Revenue for 4 years, with the latest figure at $35.2 million in Q4 2013.

• On a quarterly basis, Revenue rose 1328.04% year-over-year to $35.2 million in Q4 2013; TTM through Dec 2013 was $41.1 million, a 277.58% increase from a year earlier, with the FY2013 full-year figure at $41.1 million, up 277.58% from the prior year.
• Revenue was $35.2 million for Q4 2013 at Filana Therapeutics, up from $2.0 million in the prior quarter.
• The five-year high for Revenue was $35.2 million in Q4 2013, with the low at $2.0 million in Q1 2013.
• Average Revenue over 4 years is $5.1 million, with a median of $2.7 million recorded in 2011.
• The sharpest annual moves came in 2011 and 2013: Revenue tumbled 65.7% in 2011, then jumped 1328.04% in 2013.
• Over 4 years, Revenue stood at $8.0 million in 2010, then sank by 65.7% to $2.7 million in 2011, then decreased by 10.16% to $2.5 million in 2012, then surged by 1328.04% to $35.2 million in 2013.
• The last three Revenue figures came in at $35.2 million (Q4 2013), $2.0 million (Q3 2013), and $2.0 million (Q2 2013), per Business Quant data.